about
Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum DisorderNeuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography.Neuromyelitis optica: clinical features, immunopathogenesis and treatment.Brain Tissue Volumes and Perfusion Change with the Number of Optic Neuritis Attacks in Relapsing Neuromyelitis Optica: A Voxel-Based Correlation Study.Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.Epigallocatechin-3-gallate: a useful, effective and safe clinical approach for targeted prevention and individualised treatment of neurological diseases?Visualization of inflammation and demyelination in 2D2 transgenic mice with rodent MRI.Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.[Optical coherence tomography in neuromyelitis optica spectrum disorders].Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy.Optical Coherence Tomography versus Visual Evoked Potentials for Detecting Visual Pathway Abnormalities in Patients with Neuromyelitis Optica Spectrum Disorder.Cerebral Blood Flow Changes in Multiple Sclerosis and Neuromyelitis Optica and Their Correlations With Clinical Disability.Comparison of probabilistic tractography and tract-based spatial statistics for assessing optic radiation damage in patients with autoimmune inflammatory disorders of the central nervous system.
P2860
Q28076588-E49F6190-D846-4B6E-B2AB-D34CA012C171Q30649660-5AAA1897-1519-4279-99C6-D1E75F223933Q30785267-931296D7-AD8D-4B88-BF3A-9317056FBAD4Q34793304-6CC3EA23-34B7-40AC-8797-AECCF72E09A1Q35052199-E6AC8D8C-5014-4F8E-9A7A-7F27CEBF5A54Q36058632-E083FF0B-13B1-477D-83C3-7EE1E2D52FCBQ36648907-284050F3-FE28-41BD-B5DC-16A476AA3721Q37340961-E040ACFC-0478-43F0-B172-C884D830FE38Q42361527-391642F1-26F1-43D9-A797-D40C4F02E342Q50101454-01CE5A30-608A-4A5B-878F-4DDD78E8337FQ52668258-82EE3803-BC7F-4DBC-92E3-C20D443DE7BFQ52674606-58089BF6-2EC6-41D8-9D79-ACB460DCC9D4Q54935884-0A9DE206-1091-4C30-ACD8-9838CB02FCDCQ55426467-CC28C69E-C677-4541-A035-904C8510E833
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Imaging the visual pathway in neuromyelitis optica.
@en
Imaging the visual pathway in neuromyelitis optica.
@nl
type
label
Imaging the visual pathway in neuromyelitis optica.
@en
Imaging the visual pathway in neuromyelitis optica.
@nl
prefLabel
Imaging the visual pathway in neuromyelitis optica.
@en
Imaging the visual pathway in neuromyelitis optica.
@nl
P2860
P356
P1476
Imaging the visual pathway in neuromyelitis optica.
@en
P2093
Caspar F Pfueller
Friedemann Paul
P2860
P304
P356
10.1155/2011/869814
P577
2011-03-16T00:00:00Z